Treatment(s) now being considered-Immunotherapy Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Immunotherapy Posts on Medivizor

Evaluating the risk of lung inflammation associated with immunotherapy in advanced melanoma.

Evaluating the risk of lung inflammation associated with immunotherapy in advanced melanoma.

Posted by on Dec 31, 2021 in Melanoma | 0 comments

In a nutshell This study evaluated the risk of pneumonitis (inflammation of the lung tissue) associated with immune checkpoint inhibitors (ICIs) for the treatment of patients with advanced melanoma. The data showed that ICIs were associated with a higher risk of pneumonitis compared with conventional chemotherapy in patients with advanced melanoma. Some...

Read More

Investigating the side effect profiles of different PD-L1/PD-1 inhibitor-based combination therapies.

Investigating the side effect profiles of different PD-L1/PD-1 inhibitor-based combination therapies.

Posted by on Nov 7, 2021 in Prostate cancer | 0 comments

In a nutshell This study investigated the side effect profiles of different PD-1/PD-L1 inhibitor-based combination therapies. The data showed that PD-1/PD-L1 inhibitors in combination with chemotherapy were associated with a higher risk of treatment-related side effects than with targeted therapy or immunotherapy combinations. Some background...

Read More

Is cancer treatment with immune checkpoint inhibitors associated with infection risk?

Is cancer treatment with immune checkpoint inhibitors associated with infection risk?

Posted by on Oct 9, 2021 in Colorectal cancer | 0 comments

In a nutshell This study is aimed to evaluate the risk of infection for patients who are treated with immune checkpoint inhibitors (ICI) for solid tumors. The study concluded that in frail patients, ICI therapy alone is safer compared to chemotherapy (CT).   Some background Immunotherapy is a type of cancer treatment that makes use of the immune...

Read More

Is cancer treatment with immune checkpoint inhibitors associated with infection risk?

Is cancer treatment with immune checkpoint inhibitors associated with infection risk?

Posted by on Oct 9, 2021 in Prostate cancer | 0 comments

In a nutshell This study is aimed to evaluate the risk of infection for patients who are treated with immune checkpoint inhibitors (ICI) for solid tumors. The study concluded that in frail patients, ICI therapy alone is safer compared to chemotherapy (CT).   Some background Immunotherapy is a type of cancer treatment that makes use of the immune...

Read More

Evaluating the risk of heart-related side effects in patients treated with immune checkpoint inhibitors

Evaluating the risk of heart-related side effects in patients treated with immune checkpoint inhibitors

Posted by on Dec 31, 2020 in Melanoma | 0 comments

In a nutshell This study evaluated the risk of heart-related (HR) side effects in patients with melanoma treated with immune checkpoint inhibitors (ICI). Patients with melanoma were shown to have a higher risk of developing HR side effects when treated with ICIs. Some background ICIs are a type of cancer therapy used to treat a wide variety...

Read More

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Posted by on Jun 28, 2020 in Melanoma | 0 comments

In a nutshell The study monitored the occurrence of possible immune-related side effects (irSEs) in patients with advanced melanoma under single and combination therapy of ipilimumab (I; Yervoy), nivolumab (N; Opdivo), and pembrolizumab (P; Keytruda). The authors found that combination therapy increases the frequency of irSEs. Some background...

Read More

What gut-related side effects do immunotherapy drugs and chemotherapy cause patients with cancer?

Posted by on Apr 14, 2020 in Breast cancer | 0 comments

In a nutshell This study examined if certain immunotherapy drugs increased the risk of developing side effects in the gut in patients with cancer also receiving chemotherapy. The results showed that immunotherapy drugs increased the risks of developing gut-related side effects compared to chemotherapy alone. Some background Immunotherapy drugs that...

Read More

What gut-related side effects do immunotherapy drugs and chemotherapy cause patients with cancer?

Posted by on Apr 14, 2020 in Melanoma | 0 comments

In a nutshell This study examined if certain immunotherapy drugs increased the risk of developing side effects in the gut in patients with cancer also receiving chemotherapy. The results showed that immunotherapy drugs increased the risks of developing gut-related side effects compared to chemotherapy alone. Some background...

Read More

What types of skin-related side effects do biological treatments cause in patients with melanoma?

Posted by on Apr 3, 2020 in Melanoma | 0 comments

In a nutshell This article reviewed the types and frequency of different skin-related side effects that patients with melanoma experience while receiving biological treatments. Some background Treatment for patients with melanoma has changed in recent years from chemotherapy to biological therapies. Biological therapies include BRAF inhibitors...

Read More

Association of side effects and response to treatment in patients with melanoma treated with nivolumab

Posted by on Dec 27, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to find out if patients with melanoma who had immune system side effects after treatment with nivolumab (Opdivo) had better outcomes than patients without side effects. The study found that the patients who had side effects from using nivolumab ended up with better responses to treatment and...

Read More